TW211568B - - Google Patents

Download PDF

Info

Publication number
TW211568B
TW211568B TW081110173A TW81110173A TW211568B TW 211568 B TW211568 B TW 211568B TW 081110173 A TW081110173 A TW 081110173A TW 81110173 A TW81110173 A TW 81110173A TW 211568 B TW211568 B TW 211568B
Authority
TW
Taiwan
Prior art keywords
compound
cyclopropyl
group
quinazoline
gas
Prior art date
Application number
TW081110173A
Other languages
English (en)
Chinese (zh)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of TW211568B publication Critical patent/TW211568B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW081110173A 1991-12-20 1992-12-18 TW211568B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK912042A DK204291D0 (da) 1991-12-20 1991-12-20 Heterocykliske forbindelser deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
TW211568B true TW211568B (fr) 1993-08-21

Family

ID=8109668

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081110173A TW211568B (fr) 1991-12-20 1992-12-18

Country Status (12)

Country Link
EP (1) EP0619820A1 (fr)
JP (1) JPH07502278A (fr)
AU (1) AU673814B2 (fr)
CA (1) CA2125854A1 (fr)
DK (1) DK204291D0 (fr)
FI (1) FI942963A (fr)
IL (1) IL104099A (fr)
NO (1) NO942301L (fr)
NZ (1) NZ246558A (fr)
TW (1) TW211568B (fr)
WO (1) WO1993013103A1 (fr)
ZA (1) ZA929770B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
CN1052724C (zh) * 1996-07-01 2000-05-24 瑞安大药厂股份有限公司 新的光学活性的2,3－二氢咪唑并[1,2－c]喹唑啉衍生物及其制备方法和用途
KR100864364B1 (ko) 2005-12-13 2008-10-17 주식회사 엘지화학 신규한 이미다조퀴나졸린 유도체, 이의 제조방법 및 이를이용한 유기전기소자
JP5486928B2 (ja) 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックウレアおよびカルバメートインヒビター
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (fr) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc Inhibiteurs cycliques d'urée de la 11-hydroxystéroïde déhydrogénase 1
CA2729998A1 (fr) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibiteurs de la 11 beta-hydroxysteroide deshydrogenase 1
EP2687525B1 (fr) 2008-07-25 2015-09-23 Boehringer Ingelheim International GmbH Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1
WO2010089303A1 (fr) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Inhibiteurs cycliques de la 11β-hydroxystéroïde déshydrogénase de type 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
EP2448928B1 (fr) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド 置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用
WO2011161128A1 (fr) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones comme inhibiteurs de 11-β-hsd1 pour le traitement de troubles métaboliques
WO2012059416A1 (fr) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Combinaisons pharmaceutiques destinées au traitement de troubles du métabolisme
KR20230088709A (ko) * 2020-10-16 2023-06-20 상하이 드 노보 파마테크 컴퍼니 리미티드 트리헤테로사이클릭 유도체, 이의 약학적 조성물 및 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE80392T1 (de) * 1985-10-17 1992-09-15 Novo Nordisk As Oxadiazolylacetonitrile, ihre herstellung und anwendung.
DK155524C (da) * 1987-03-18 1989-09-11 Ferrosan As Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
DK443589D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug

Also Published As

Publication number Publication date
IL104099A0 (en) 1993-05-13
EP0619820A1 (fr) 1994-10-19
CA2125854A1 (fr) 1993-07-08
WO1993013103A1 (fr) 1993-07-08
ZA929770B (en) 1994-06-17
DK204291D0 (da) 1991-12-20
JPH07502278A (ja) 1995-03-09
AU673814B2 (en) 1996-11-28
IL104099A (en) 1996-07-23
FI942963A0 (fi) 1994-06-20
NO942301L (no) 1994-08-19
NZ246558A (en) 1995-07-26
NO942301D0 (no) 1994-06-17
FI942963A (fi) 1994-06-20
AU3344893A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
TW211568B (fr)
JP4074509B2 (ja) 抗癌性化合物を製造するための方法と中間体
ES2367666T3 (es) Derivados de [4,5']bipirimidinil-6,4'-diamina como inhibidores de proteína quinasa.
JP6976947B2 (ja) 自己免疫疾患の処置に有用なビピラゾリル誘導体
TW209862B (fr)
CN103403003B (zh) 桥连哌啶衍生物
CA2673003A1 (fr) Quinazolines destines a l'inhibition de pdk1
EA005407B1 (ru) Производные бензоимидазола, используемые в качестве антипролиферативного средства
CA2045359C (fr) 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CN109890820A (zh) 用作神经营养因子酪氨酸激酶受体抑制剂的氨基吡唑并嘧啶化合物
CN103889987A (zh) 作为btk-抑制剂的4-咪唑并哒嗪-1-基-苯甲酰胺类和4-咪唑并三嗪-1-基-苯甲酰胺类
CA2727251A1 (fr) 2 -arylaminoquinazolines destinees au traitement des maladies proliferatives
EA017442B1 (ru) ПРОИЗВОДНЫЕ 2-АРИЛ-6-ФЕНИЛИМИДАЗО[1,2-a]ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
BR112015019627B1 (pt) Compostos de amidas heterocíclicas, composições farmacêuticas compreendendo ditos compostos e usos dos mesmos para tratar colite ulcerativa, doença de crohn, artrite reumatoide, psoríase, espondiloartrite, artrite idiopática juvenil de aparecimento sistêmico (sojia), osteoartrite e esclerose múltipla
CN104341425B (zh) 氘代乙炔衍生物、其药物组合物及应用
BR112015007731B1 (pt) Composto, composição farmacêutica que o compreende e uso do mesmo
JP2000309577A (ja) 抗がん剤として有用なヘテロ芳香族二環式誘導体
DE3883033T2 (de) Heterocyclische Verbindungen und ihre Herstellung und Anwendung.
US8957077B2 (en) Pyrazolopyrimidine PDE 10 inhibitors
WO2012044090A2 (fr) Nouveau composé d'aminoquinazoline possédant une action inhibitrice de la protéine kinase
CN111410659B (zh) Pde9抑制剂及其用途
CN111406054A (zh) 作为组蛋白脱乙酰基酶6抑制剂的1，2，4-噁二唑衍生物
JP2002510695A (ja) 副腎皮質刺激ホルモン放出因子（ＣＲＦ）拮抗剤としてのチアゾロ［４，５−ｄ］ピリミジンおよびピリジン
WO2021228248A1 (fr) Composé amide aza-hétérocyclique condensé et son utilisation
TW542833B (en) Benzoxazinone dopamine D4 receptor antagonists